Copyright
©The Author(s) 2020.
World J Hepatol. Jun 27, 2020; 12(6): 312-322
Published online Jun 27, 2020. doi: 10.4254/wjh.v12.i6.312
Published online Jun 27, 2020. doi: 10.4254/wjh.v12.i6.312
Follow-up time (mo) | 19.7 ± 5.8 | (10.1–29.4) | n = 24 |
Patients’ care | |||
Hospitalization | |||
In a conventional care unit | |||
Yes | 18 | (75) | n = 24 |
Duration (days) | 6.8 ± 3.1 | (2–14) | n = 18 |
In an intensive care unit | 0 | (0) | n = 24 |
Treatment | |||
UDCA | 18 | (75) | n = 24 |
Cholecystectomy | 5 | (36) | n = 14 |
Outcome | |||
Good adherence to UDCA | 12 | (67) | n = 18 |
UDCA efficacy | 17 | (94) | n = 18 |
Onset of action (in weeks) | 3.4 ± 2.5 | (2–12) | n = 17 |
Pain recurrence | 5 | (28) | n = 18 |
UDCA intolerance | 2 | (11) | n = 18 |
Death | 0 | (0) | n = 24 |
- Citation: Gille N, Karila-Cohen P, Goujon G, Konstantinou D, Rekik S, Bécheur H, Pelletier AL. Low phospholipid-associated cholelithiasis syndrome: A rare cause of acute pancreatitis that should not be neglected. World J Hepatol 2020; 12(6): 312-322
- URL: https://www.wjgnet.com/1948-5182/full/v12/i6/312.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i6.312